Atlantic Biothérapies
Located in the west of France in the Pays-de-la-Loire region, the national « Atlantic Biothérapies » cluster is specialized in the field of Biotherapies. Biotherapies form a « therapeutic arsenal » made up of: Cell and gene therapies, Immunology, Biomaterials, Radio-pharmaceuticals.
From its creation in 2005, the goal of the cluster has been to become an international benchmark in the development of diagnostic and treatment solutions in the biotherapy field.
Advantages
The Pays-de-la-Loire region offers a network of companies and research organizations working in the field of biotechnologies, capable of developing new products and services within the global market.
Partners
More than 80 partners
Companies 44
• French groups include: Groupe Grimaud, Eurofins, Silliker SAS…
• International groups include: The MarkeTech Group (United States), Thermo Fisher Scientific (United States), Intervet/Schering-Plough, ...
And SME’s
• Vivalis, TcLand, Clean Cells, IGNA, Atlantic BoneScreen, Biomatlante, In-Cell-Art, Surfactis Technologies…
Research and educational establishments
Over 40, including Angers and Nantes Universities, Centres de Lutte contre le Cancer (CLCC) Paul Papin (Angers) and René Gauducheau (Nantes), Institut de Transplantation et de Recherche en Transplantation (ITERT), Ouest Génopole, Canceropole, Institut National de la Santé et de la Recherche Médicale (INSERM), Ecole Nationale Vétérinaire de Nantes (ENVN), Centre National de la Recherche Scientifique (CNRS), Instituts Fédératifs de Recherche (IFR)…
Other organizations are also stakeholders in the cluster including the Pays-de-la-Loire Regional Council, the Maine-et-Loire and Loire-Atlantique General Councils, the French National Research Agency (ANR), Oséo, Angers Loire Métropole, Nantes Métropole…
Current R&D partnerships
30 approved projects since December 2005, representing a global budget of more than 55 million euros (see appendix)
The Inter-ministerial Joint Fund (FUI) has awarded more than 4 million euros of funding for these projects
The French National Research Agency (ANR) has awarded more than 8.5 million euros of funding
International partnerships
Current including
• Longstanding existing partnerships with other European Bioclusters : Leiden in the Netherlands, Heidelberg in Germany, Milan in Italy, Cardiff in the United kingdom and Gothenburg in Sweden, as part of European programs or the Bio-regions European Council (CEBR)
• Recent Partnership with the Madrid Biocluster for two projects : IMI and BiotherIP
• Participation in the Bio San Diego 2008 international convention, enabling the cluster’s member companies to set up technological partnerships. More than 200 meetings took place between
• « French Bio Sea » network with Seattle Area Biotechnology Companies
Future including
• Partnerships in India
• Partnerships currently under discussion with North Carolina (Research Triangle Park)
Appendix Exemples de Projets labellisés R&D
|
Project name and subject |
Steered by |
|
Industrial projects |
|
|
Anti HepC Molecules |
Vivalis - Idealp - AFMB |
|
EBx Therapeutic proteines |
Vivalis - Clean Cells |
|
PhosphoProteomeArray Development of high performance protein micro-chips to analyze phospho-proteomes |
Protneteomix |
|
ATOS Cell-Material Combinations for Bone Cell Therapies |
Biomatlante, Clean Cells |
|
MUTEC Develop a bio-chip able to rapidly detect DNA mutations |
MHS Electronics |
|
NANOMIC Micrometastsis micro-diagnostics |
Protneteomix |
|
« Emergence-Maturation » projects |
|
|
Laboratory project maturing likely to result in the creation of new technology companies or technology transfer towards private industry |
|
|
Hepatic Fibrosis Study of hepatic fibrosis (Fibrous tissue that develops in areas where hepatic cells have been destroyed) |
Université d’Angers Laboratoire Hémodynamique, Interactions Fibrose, et Invasivité Tumorales Hépatiques (HIFIH) |
|
Theraximab New therapeutic anti-tumor antibody |
Institut National de |
|
Academic projects |
|
|
Teams belonging the cluster, association with the cluster’s scientific themes and ultimate valoriztion potential for the cluster |
|
|
ATAVIH Assistance in early diagnosis of efficiency of anti-HIV treatments |
Institut de Recherche en Communication et Cybernétique de Nantes (IRCCyN) |
|
Pentraximmune Role of soluble receptor in innate immunity |
Institut National de |
|
Structure Projects |
|
|
CEFBIOP Etablissement de Formation à Training of qualified manpower to work in this sector |
Vivalis, Clean Cells |
|
LEX Laboratoire d'Expression recombinante Project to encourage the federating, enriching and marketing of the cluster’s expertise for the manufacture of biological therapeutic products, backed up by a training program |
Clean Cells |
|
CIMNA Setting up an immuno-monitoring platform |
Centre Hospitalier Universitaire (CHU) de Nantes |
|
Clinical projets |
|
|
MESANI Cell therapy for chronic ischemic-related cardiac failure (reduction in the supply of blood to the organ) |
Centre Hospitalier Universitaire (CHU) de Nantes |
|
CENTAURE Themed Network of Research into Treatment and Transplantation |
Centre Hospitalier Universitaire (CHU) de Nantes et Hôpital Necker Paris |
- More information on Atlantic Biotherapies
Contact
Invest in France Agency Paris
Laurent BERGEOT
Director, Territories Development
Send an e-mail
+33 1 40 74 74 11